Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Advanced Micro Devices stock (NASDAQ:AMD) increased by more than 4% during Tuesday's trading session and has risen by nearly ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

Advanced Micro Devices is scheduled to report first-quarter earnings after the bell on Tuesday, and traders are expecting a ...

Advanced Micro Devices has an undervalued stock and strong fundamentals, driven by growth catalysts and strategic moves.

AMD stock price has bounced back in the past few days as investors cheered the company’s upbeat financial results.

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Advanced Micro Devices' (AMD) stock whipsawed in early trading Wednesday morning as investors digested the company's better-than-anticipated Q1 earnings report and stronger-than-expected outlook ...

Advanced Micro Devices stock (NASDAQ:AMD ... Q1 Earnings AMD’s Q1 results were also better than expected, with its outlook for Q2 also coming in ahead of estimates. Revenue rose by 36% ...

Advanced Micro Devices shares fell Thursday after gaining ground for six consecutive days amid optimism about recently announced AI deals and share buyback plans. Monitor these crucial support and ...

Advanced Micro Devices (NASDAQ: AMD) saw its stock climb over 5% in after-hours trading on Tuesday after reporting ...